These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17919799)

  • 1. Comments on "Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder".
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):597-8. PubMed ID: 17919799
    [No Abstract]   [Full Text] [Related]  

  • 2. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
    Kang RH; Wong ML; Choi MJ; Paik JW; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1317-21. PubMed ID: 17618721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of 5-HTT and HTR1A gene polymorphisms in treatment responses to mirtazapine in patients with major depressive disorder.
    Chang HS; Lee HY; Cha JH; Won ES; Ham BJ; Kim B; Lee MS
    J Clin Psychopharmacol; 2014 Aug; 34(4):446-54. PubMed ID: 24911443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
    Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
    Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression.
    Kang RH; Chang HS; Wong ML; Choi MJ; Park JY; Lee HY; Jung IK; Joe SH; Kim L; Kim SH; Kim YK; Han CS; Ham BJ; Lee HJ; Ko YH; Lee MS; Lee MS
    J Psychopharmacol; 2010 Dec; 24(12):1755-63. PubMed ID: 19493959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional dyspepsia and mirtazapine.
    Lee SY; Rho SH; Choi SC
    Can J Psychiatry; 2002 Aug; 47(6):582-3. PubMed ID: 12211889
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression.
    Kang RH; Choi MJ; Paik JW; Hahn SW; Lee MS
    Int J Psychiatry Med; 2007; 37(3):315-29. PubMed ID: 18314859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of ARRB1 polymorphisms with the risk of major depressive disorder and with treatment response to mirtazapine.
    Chang HS; Won ES; Lee HY; Ham BJ; Kim YG; Lee MS
    J Psychopharmacol; 2015 May; 29(5):615-22. PubMed ID: 25294870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirtazapine for alcohol dependence: a case report.
    Crockford DN; White WD
    J Clin Psychiatry; 2005 Apr; 66(4):540. PubMed ID: 15816801
    [No Abstract]   [Full Text] [Related]  

  • 10. Mirtazapine: not a dual action antidepressant?
    Gillman PK
    Aust N Z J Psychiatry; 2004 Apr; 38(4):266-7. PubMed ID: 15038808
    [No Abstract]   [Full Text] [Related]  

  • 11. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
    Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt DJ; Metspalu A
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):451-6. PubMed ID: 19272758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacologic rationale for the clinical use of antidepressants.
    Pinder RM
    J Clin Psychiatry; 1997 Nov; 58(11):501-8. PubMed ID: 9413422
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients.
    Peña S; Baccichet E; Urbina M; Carreira I; Lima L
    Int Immunopharmacol; 2005 Jun; 5(6):1069-76. PubMed ID: 15829422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between G-protein beta-3 subunit C825T polymorphism and mirtazapine responses in Korean patients with major depression.
    Kang RH; Hahn SW; Choi MJ; Lee MS
    Neuropsychobiology; 2007; 56(1):1-5. PubMed ID: 17943025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mirtazapine on sleep polygraphic variables in major depression.
    Schittecatte M; Dumont F; Machowski R; Cornil C; Lavergne F; Wilmotte J
    Neuropsychobiology; 2002; 46(4):197-201. PubMed ID: 12566938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of mirtazapine: dual action or dual effect?
    Norman TR
    Aust N Z J Psychiatry; 2004 Apr; 38(4):267-9; author reply 269. PubMed ID: 15038809
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mirtazapine--the new standard].
    Fortschr Neurol Psychiatr; 1999 Aug; 67(8 Suppl):1-4. PubMed ID: 10511867
    [No Abstract]   [Full Text] [Related]  

  • 18. Mirtazapine for depression in patients with human immunodeficiency virus.
    Elliott AJ; Roy-Byrne PP
    J Clin Psychopharmacol; 2000 Apr; 20(2):265-7. PubMed ID: 10770469
    [No Abstract]   [Full Text] [Related]  

  • 19. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
    Laakmann G; Hennig J; Baghai T; Schüle C
    Ann N Y Acad Sci; 2004 Dec; 1032():279-82. PubMed ID: 15677428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.